Abstract:Objectives: The disease modifying therapies (DMTs) for multiple sclerosis (MS) are expensive and a burden on healthcare systems. Decisions driving the reimbursement of currently available DMTs can help prepare appropriate strategies for pricing and reimbursement submissions in future. The objective of this analysis was to understand recent health technology assessments (HTAs) for MS therapies in EU-5 nations and identify the factors driving their reimbursement decisions. Methods: European Commission (EC)-appro… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.